Forbes November 5, 2019
To fulfill its promise precision medicine requires accurate decision support tools, especially to streamline biomarker testing so that the appropriate targeted therapies are prescribed. Even in oncology, where precision medicine has advanced the farthest compared to other therapeutic categories, clinical decision tools are needed to sort through and analyze reams of clinical and molecular data for the purpose of optimizing treatment algorithms.
Elsevier’s Via Oncology, for example, operates a clinical decision support tool called Via Pathways, designed to inform the appropriate use of biomarker tests and corresponding targeted therapies. According to Dr. Richard Loomis, Chief Informatics Officer, Clinical Solutions at Elsevier, the tool “can reduce unnecessary variation in outcomes.”
A recent study found that only 11.3% of non-small cell lung...
Today's Sponsors
Today's Sponsor